Pediatrix schedules October 29 results for Pediatrix Medical Group stock

Published on 10/20/2026 at 21:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Business Wire dates results for October 29, 2026 at 9:00 a.m. ET. Pediatrix Medical Group stock costs EUR 25.10 on October 20, 2026 after hours.

October results date set

Business Wire reported on October 20, 2026 that Pediatrix will discuss third-quarter results on October 29, 2026.
Second-quarter revenue reached USD 487.78 million and adjusted earnings per share reached USD 0.63.
Pediatrix Medical Group stock costs EUR 25.10 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST.

MD, US58502B1061, Illustration mit AI erstellt.

Pediatrix Medical Group (ISIN US58502B1061) scheduled its third-quarter results call for October 29, 2026 at 9:00 a.m. ET, a date confirmed by Business Wire. The company will discuss results for the quarter ended September 30, 2026. Pediatrix Medical Group stock was trading at EUR 25.10 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST.

October 29 brings the next test

The scheduled call gives investors a defined date for the next operating update. Pediatrix said the detailed release will be issued before US markets open on October 29, 2026, followed by the conference call and webcast at 9:00 a.m. ET, according to Business Wire.

Second-quarter figures set the baseline

The latest reported quarter provides the clearest operating benchmark. Pediatrix generated USD 487.78 million in second-quarter revenue, up 4.10 percent from the prior year, while adjusted earnings per share reached USD 0.63 versus USD 0.53 a year earlier, according to MarketBeat. Revenue also exceeded the reported consensus estimate of USD 478.49 million by USD 9.29 million.

Stock position remains near its high

On the NYSE, Pediatrix Medical Group was last quoted at USD 28.27 on October 20, 2026 at 3:53 p.m. ET. The same quote placed the 52-week range at USD 16.82 to USD 28.28, with a market capitalization of USD 2.3 billion and a price-to-earnings ratio of 13.50.

What will the October date clarify?

The third-quarter release should provide the next periodized comparison for revenue and earnings, while management is also expected to discuss full-year 2026 guidance. Pediatrix provides physician services in obstetrics, maternal-fetal medicine, neonatology and pediatric subspecialties. The company said it has approximately 4,300 affiliated physicians and other clinicians in its October 20, 2026 release.

Stock stays in the healthcare frame

Pediatrix operates in healthcare services, with its business centered on specialized care for women, babies and children. For investors, the October 29 reporting date is the next concrete checkpoint for testing whether the second-quarter revenue growth and earnings improvement continued.

Trading after the Xetra session

Pediatrix Medical Group stock was trading at EUR 25.10 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Pediatrix Medical Group stock.